Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on AVINGTRANS PLC. We currently have 32 research reports from 4 professional analysts.
|09Jan17 12:45||RNS||Holding(s) in Company|
|04Jan17 03:56||RNS||Holding(s) in Company|
|03Jan17 12:47||RNS||Holding(s) in Company|
|22Dec16 06:25||RNS||Share Incentive Awards Issue of Equity and TVR|
|21Dec16 01:59||RNS||Share Incentive Awards|
|13Dec16 04:00||RNS||Exercise of Share Options|
|13Dec16 02:15||RNS||Exercise of Share Options & PDMR Share Dealing|
Frequency of research reports
Research reports on
19 Dec 16
600 GROUP | ACCSYS TECHNOLOGIES | AGGREGATED MICRO POWER HLDGS PLC | ALUMASC GROUP | ANGLO-EASTERN PLANTATIONS | AVINGTRANS PLC | CAPITAL DRILLING LTD | CARCLO | FENNER PLC | FLOWTECH FLUIDPOWER PLC | GLOBAL INVACOM GROUP LTD | GOOCH & HOUSEGO PLC | HARDIDE PLC | HAYWARD TYLER GROUP PLC | IOFINA PLC | M.P.EVANS GROUP | R.E.A. HLDGS PLC | REDT ENERGY PLC | RENOLD | ROBINSON | SOMERO ENTERPRISE INC | SURFACE TRANSFORMS PLC | TRANSENSE TECHNOLOGIES PLC | TRIFAST | ZAMBEEF PRODUCTS
N+1 Singer - Avingtrans - Result of tender offer
08 Nov 16
Avingtrans has announced the results of its tender offer, which was announced at the start of October. Under the offer c.9.7m shares were tendered, equivalent to c.35% of the shares in issue. These will be purchased at 200p, for a total price of c.£19.4m. This will leave the group with c.£28m for investment in the remaining Energy & Medical operations, to repeat its successful buy & build strategy.
N+1 Singer - Avingtrans - Tender offer details announced
03 Oct 16
Avingtrans has announced the terms of its proposed tender offer. Each shareholder is entitled to have up to 50% of their shareholding purchased at the tender price of 200p per share, with potential for additional shares to be purchased subject to the number of shares tendered by other shareholders. The tender offer period runs from 3rd October to 4th November.
29 Sep 16
Cambridge Cognition Holdings* (COG.L) | Edenville Energy (EDL.L) | Avingtrans (AVG.L) | Gaming Realms (GMR.L) | Redstone Connect (REDS.L) | Concurrent Technologies (CNC.L) | Porta Communications (PTCM.L) | Galantas Gold (GAL.L) | Range Resources (RRL.L) | Plutus Power Gen (PPG.L)
N+1 Singer - Morning Song 27-09-2016
27 Sep 16
Sarepta’s accelerated approval last week of EXONDYS 51™ for the treatment of around 13% of DMD patients is a significant milestone in the DMD market. We believe this sets a precedent for companies such as Summit and its utrophin modulation programme. Ezutromid, Summit’s lead DMD programme, commenced a Phase II proof-of-concept trial (PhaseOut DMD) in the UK in June. The first muscle biopsy data is expected Q2/Q3 2017. We take the opportunity to assess Summit’s offering in the context of recent developments in the DMD market and, in particular, we draw investors’ attention to the rapid share price appreciation of the main DMD plays.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
N+1 Singer - Small-cap quantitative research - Momentum screen refresh + 10 focus stocks
12 Jan 17
We have refreshed our momentum style screen for the first time since inception on 26 July 2016. As before, the screen selects the 25 stocks exhibiting the most extreme momentum characteristics, according to our measurement method. From these we have selected 10 to focus on. Since inception the screen has underperformed both the main small-cap and micro-cap indices against a background of generally rising momentum. We have noted a subset of the basket, where decelerating momentum at the time of measurement appears correlated with significant share price falls since selection. We shall monitor this factor with the new screen, albeit there are only two such stocks showing this pattern, namely Lamprell (not rated) and Gear4music (not rated).
N+1 Singer - Morning Song 12-01-2017
12 Jan 17
As anticipated, the second half has again been stronger than H1 and results will be broadly in line with expectations. In line with this, the order book has continued to grow and is at record levels. This confirms that significant progress has been made in the Group’s shift towards its Technology Products division which, as targeted, contributed c.60% of group revenue in FY16. The small acquisition of Cable Power also gives a complementary boost to the product range. It is also worth noting the significant reduction in net debt, £1.0m ahead of our forecast. We remain supportive of the Group’s strategy and continue to see a bright future as this transition towards a design led technology solutions business continues. We look forward to more detail in March at the final results.
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.